49
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      MICU1 controls both the threshold and cooperative activation of the mitochondrial Ca²⁺ uniporter.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mitochondrial Ca(2+) uptake via the uniporter is central to cell metabolism, signaling, and survival. Recent studies identified MCU as the uniporter's likely pore and MICU1, an EF-hand protein, as its critical regulator. How this complex decodes dynamic cytoplasmic [Ca(2+)] ([Ca(2+)]c) signals, to tune out small [Ca(2+)]c increases yet permit pulse transmission, remains unknown. We report that loss of MICU1 in mouse liver and cultured cells causes mitochondrial Ca(2+) accumulation during small [Ca(2+)]c elevations but an attenuated response to agonist-induced [Ca(2+)]c pulses. The latter reflects loss of positive cooperativity, likely via the EF-hands. MICU1 faces the intermembrane space and responds to [Ca(2+)]c changes. Prolonged MICU1 loss leads to an adaptive increase in matrix Ca(2+) binding, yet cells show impaired oxidative metabolism and sensitization to Ca(2+) overload. Collectively, the data indicate that MICU1 senses the [Ca(2+)]c to establish the uniporter's threshold and gain, thereby allowing mitochondria to properly decode different inputs.

          Related collections

          Author and article information

          Journal
          Cell Metab
          Cell metabolism
          Elsevier BV
          1932-7420
          1550-4131
          Jun 04 2013
          : 17
          : 6
          Affiliations
          [1 ] Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
          [2 ] Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
          [3 ] Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Systems Biology, Harvard Medical School and Broad Institute, Cambridge, MA 02142, USA.
          [4 ] Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Systems Biology, Harvard Medical School and Broad Institute, Cambridge, MA 02142, USA; Gene Center, Ludwig-Maximilians-Universität, Munich D-81377, Germany.
          [5 ] Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
          [6 ] Alnylam Pharmaceuticals Inc., Cambridge, MA 02142, USA.
          [7 ] Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Systems Biology, Harvard Medical School and Broad Institute, Cambridge, MA 02142, USA. Electronic address: vamsi@hms.harvard.edu.
          [8 ] Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA. Electronic address: gyorgy.hajnoczky@jefferson.edu.
          Article
          S1550-4131(13)00193-9 NIHMS479782
          10.1016/j.cmet.2013.04.020
          3722067
          23747253
          6a7f4e87-7c90-489e-a4f2-b8f907f13746
          Copyright © 2013 Elsevier Inc. All rights reserved.
          History

          Comments

          Comment on this article